Label (51655 044 52 Rev A 11 23)
Amlodipine Besylate Tablet
Product Images NDC 51655-044
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 51655-044). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (Dc48db65 Ee80 4852 A3aa A23ec74f4416 01)
Image2 (Dc48db65 Ee80 4852 A3aa A23ec74f4416 02)
This text appears to provide information related to an event rate analysis. The P-value is reported as 0.003, indicating a statistically significant result. The Hazard Ratio is given as 0.691, suggesting a lower risk or incidence of the event. Additionally, a 95% confidence interval is provided as (0.54, 0.88), showing the range of likely values for the effect size. The numbers 12, 18, and 24 may indicate different time intervals or time points of interest. The term "Amlodipine" could potentially refer to a treatment or intervention being evaluated. However, without further context or clarity, it is difficult to provide a more specific interpretation.*
Image3 (Dc48db65 Ee80 4852 A3aa A23ec74f4416 03)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
